Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Leupaxin Expression Is Dispensable for B Cell Immune Responses.
Bonaud A, Clare S, Bisio V, Sowerby JM, Yao S, Ostergaard H, Balabanian K, Smith KGC, Espéli M. Bonaud A, et al. Among authors: bisio v. Front Immunol. 2020 Mar 25;11:466. doi: 10.3389/fimmu.2020.00466. eCollection 2020. Front Immunol. 2020. PMID: 32269569 Free PMC article.
Targeting the plasticity of mesenchymal stromal cells to reroute the course of acute myeloid leukemia.
Borella G, Da Ros A, Borile G, Porcù E, Tregnago C, Benetton M, Marchetti A, Bisio V, Montini B, Michielotto B, Cani A, Leszl A, Campodoni E, Sandri M, Montesi M, Bresolin S, Cairo S, Buldini B, Locatelli F, Pigazzi M. Borella G, et al. Among authors: bisio v. Blood. 2021 Aug 19;138(7):557-570. doi: 10.1182/blood.2020009845. Blood. 2021. PMID: 34010415 Free article.
Prevalence of UBA1 mutations in MDS/CMML patients with systemic inflammatory and auto-immune disease.
Zhao LP, Schell B, Sébert M, Kim R, Lemaire P, Boy M, Mathis S, Larcher L, Chauvel C, Dhouaieb MB, Bisio V, Preudhomme C, Marceau-Renaut A, Itzykson R, Mekinian A, Fain O, Toubert A, Fenaux P, Dulphy N, Clappier E, Adès L. Zhao LP, et al. Among authors: bisio v. Leukemia. 2021 Sep;35(9):2731-2733. doi: 10.1038/s41375-021-01353-8. Epub 2021 Aug 3. Leukemia. 2021. PMID: 34344988 No abstract available.
Core-binding factor acute myeloid leukemia in pediatric patients enrolled in the AIEOP AML 2002/01 trial: screening and prognostic impact of c-KIT mutations.
Manara E, Bisio V, Masetti R, Beqiri V, Rondelli R, Menna G, Micalizzi C, Santoro N, Locatelli F, Basso G, Pigazzi M. Manara E, et al. Among authors: bisio v. Leukemia. 2014 May;28(5):1132-4. doi: 10.1038/leu.2013.339. Epub 2013 Nov 14. Leukemia. 2014. PMID: 24226631 Clinical Trial. No abstract available.
Minimal residual disease monitored after induction therapy by RQ-PCR can contribute to tailor treatment of patients with t(8;21) RUNX1-RUNX1T1 rearrangement.
Pigazzi M, Manara E, Buldini B, Beqiri V, Bisio V, Tregnago C, Rondelli R, Masetti R, Putti MC, Fagioli F, Rizzari C, Pession A, Locatelli F, Basso G. Pigazzi M, et al. Among authors: bisio v. Haematologica. 2015 Mar;100(3):e99-101. doi: 10.3324/haematol.2014.114579. Epub 2014 Dec 5. Haematologica. 2015. PMID: 25480496 Free PMC article. No abstract available.
25 results